Northeast Ohio’s coordinated effort to combat cancer has earned an extraordinary endorsement from the National Cancer Institute (NCI): its highest-possible rating and $31.9 million to continue its lifesaving work. The rating of “exceptional” comes as the Case Comprehensive Cancer Center–a collaboration among Case Western Reserve University, Cleveland Clinic and University Hospitals–celebrates its 30th anniversary of … Read More
News Releases
Cleveland Clinic Names Chief of Population Health and Director of Cleveland Clinic Community Care
Adam Myers, M.D., MHCM, FACHE, will join Cleveland Clinic as Chief of Population Health and director of Cleveland Clinic Community Care, Cleveland Clinic’s new population health approach. Dr. Myers has broad experience in population health as a model for improving healthcare quality while reducing costs. Cleveland Clinic Community Care takes a new, population health approach … Read More
AHA Awards Cleveland Clinic $3.7 Million for Atrial Fibrillation Research
The American Heart Association (AHA) has awarded Cleveland Clinic a $3.7 million grant for atrial fibrillation research. The four-year, competitive award will support three synergistic projects aimed at improving outcomes for patients with atrial fibrillation (AFib), a common heart rhythm abnormality. Cleveland Clinic was selected as one of six research institutions across the country to … Read More
Cleveland Clinic Center for Functional Medicine Suite Receives WELL Certification
Cleveland Clinic’s Center for Functional Medicine Suite is one of the first medical offices to be awarded WELL Certification, a new building standard that integrates human health into building design and operation. The WELL Building Standard evaluates a building’s performance based on seven core concepts: air quality, water quality, healthy foods, light quality, integration of … Read More
Cleveland Clinic Cancer Center Experts Present Data at 2018 ASCO Annual Meeting
CHICAGO: Researchers from Cleveland Clinic Cancer Center will present data from several new studies at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, including a prospective clinical trial examining non-small cell lung cancer cells’ response to immunotherapy; research on germline testing for melanoma; and interim results from a study testing a vaccine … Read More
Cleveland Clinic Researchers Find Leukemia and Lymphoma Drug May Benefit Patients with Glioblastoma
New Cleveland Clinic research shows for the first time that ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also help treat the most common – and deadliest – type of brain tumor. The findings, published in Science Translational Medicine, offer hope that the drug may one day be used in patients with glioblastoma and … Read More
Cleveland Clinic’s Patient Experience: Empathy + Innovation Summit Draws National Experts
Cleveland Clinic’s ninth annual Patient Experience: Empathy + Innovation Summit, will bring together patient experience leaders, healthcare CEOs, policy leaders, designers and innovators from across the country and world to discuss vital healthcare and experience topics, such as technology and innovation, access, quality and safety, and continuous improvement. The summit is being held June 18-20 … Read More
Cleveland Clinic Appoints New Chair of Gastroenterology & Hepatalogy
Cleveland Clinic recently appointed Miguel Regueiro, M.D., as the new chair of the Department of Gastroenterology & Hepatology. In this role, Dr. Regueiro will focus on expanding Cleveland Clinic’s patient-centered care for chronic digestive diseases, using a multispecialty, population-health approach. Dr. Regueiro’s work with patients who have inflammatory bowel disease (IBD) led to a new … Read More
Cleveland Clinic-led Study Finds that More than 40 Percent of Prostate Biopsies Could Have Been Avoided with New Blood Test
San Francisco: A multi-center study that validates the clinical performance of IsoPSA – a new blood test that has proven to be more accurate in predicting overall risk of prostate cancer than standard prostate-specific antigen (PSA) – will be presented during a special press conference at the 13th Annual Meeting of the American Urological Association … Read More
Cleveland Clinic Researcher Receives $2M Grant to Study Role of Cancer’s Genetic Composition in Predicting the Effectiveness of Radiation Therapy
Can the genetic makeup of their cancers predict how patients with lung cancer will respond to radiation therapy? And can this information be used to advance a genetically guided strategy for patients with these tumors? Cleveland Clinic researcher and radiation oncologist Mohamed Abazeed, M.D., Ph.D., has been awarded a $2 million grant from the National … Read More